Literature DB >> 19775613

Salvage radiotherapy in patients with persisting/rising PSA after radical prostatectomy for prostate cancer.

Dirk Bottke1, Theo M de Reijke, Detlef Bartkowiak, Thomas Wiegel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19775613     DOI： 10.1016/S0959-8049(09)70027-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.

Authors:  A Gómez Caamaño; A Zapatero; J López Torrecilla; X Maldonado
Journal:  Clin Transl Oncol       Date:  2015-11-30       Impact factor: 3.405

2.  [Radiation therapy for prostate cancer in the new S3 guideline. Part 2: postoperative radiation therapy and brachytherapy].

Authors:  T Martin; F Wenz; D Böhmer; F Sedlmayer; W Hinkelbein; T O Henkel; K Miller; T Wiegel
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

3.  Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study.

Authors:  Alessandra Siegmann; Dirk Bottke; Julia Faehndrich; Gunnar Lohm; Kurt Miller; Detlef Bartkowiak; Thomas Wiegel; Wolfgang Hinkelbein
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

4.  Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer Center.

Authors:  Olivier Riou; Pascal Fenoglietto; Benoit Laliberté; Cathy Menkarios; Carmen Llacer Moscardo; Meng Huor Hay; Norbert Ailleres; Jean-Bernard Dubois; Xavier Rebillard; David Azria
Journal:  ISRN Urol       Date:  2012-03-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.